Treatment Posts

Healthcare at Home – product recall statement

Healthcare at Home have been advised by the Medicines and Healthcare products Regulatory Agency (MHRA)…
Read more

The Haemophilia Society responds to NICE Consultations

Starting in 2020, NICE has been running a series of consultations looking at their processes for health…
Read more

Update to Hemlibra (emicizumab) Convenience Kits

Following approval from the European Medicines Agency (EMA) last August, Roche-Chugai will be introducing updated…
Read more

Share your thoughts on the services for people with bleeding disorders

Do you have or care for someone with a bleeding disorder? How can we improve…
Read more

Fitusiran update following EAHAD 2021 Congress

During the Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) in early February 2021, Sanofi…
Read more

New guidelines for diagnosis and management of von Willebrand Disease published

Von Willebrand Disease (VWD) is the most common hereditary bleeding disorder and there is a…
Read more

Join us on Saturday 14 November for our online bleeding disorders conference

We’ve brought together experts in bleeding disorder care to talk about treatment, give practical advice…
Read more

EHC Statement on Desmopressin Nasal Sprays availability

Late last week, we were informed of an international recall of all Ferring Parmaceuticals Limited nasal sprays…
Read more

Home delivery – tell us about it

If you get your medication through home delivery, we would like to hear from you….
Read more

New Framework for products for Haemophilia A

A new framework for buying medicines to manage Haemophilia A came into force across the…
Read more

Second chance for recombinant VWD factor

If you have von Willebrand disease, we would like your views on a new synthetic…
Read more

Peer Review report on centres published today

Today sees the publication of the Overview Report of the Inherited and Acquired Haemophilia and…
Read more